Interview: Francisco González Díaz – CEO, ProMéxico

Francisco González DíazFrancisco González, CEO of ProMéxico, the Mexican investment agency, describes the strengths of Mexico’s research and industrial base, untapped business opportunities in the pharmaceutical and healthcare sectors, and new export horizons in Africa and Asia. Mexico currently displays a very interesting business context: the economy is back to robust growth and is further accelerating, the employment rate stands at an all-time high, while FDI in Mexico jumped 18 percent between 2014 and 2015, and also reached an all-time high at USD 7.9 billion for the first quarter 2016. As CEO of ProMexico, which is notably in charge of promoting exports and attracting foreign direct investment, you must be particularly satisfied with this positive outlook?
We want now to move forward on strengthening and developing more healthcare-related clusters across our country.
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report